Front Line Medical recently announced that it expanded the availability of its COBRA-OS aortic occlusion device to meet growing demands.
The Ontario, Canada-based company is increasing production of the COBRA-OS (control of bleeding, resuscitation, arterial occlusion system) occluder following patient success rates and expanded interest from hospitals to treat trauma.
Get the full story on our sister site, Medical Tubing + Extrusion.
Front Line Medical Technologies today announced that its COBRA-OS bleeding control device won FDA 510(k) clearance.
The COBRA-OS (control of bleeding, resuscitation, arterial occlusion system) is a 4 French REBOA (resuscitative endovascular balloon occlusion of the aorta) device that provides full occlusion, intermittent occlusion or partial occlusion depending on a patient’s needs.
Get the full story on our sister site, Medical Tubing + Extrusion.